Teratogens are agents that interfere with normal embryonic or fetal development, causing structural birth defects, functional impairments, or both. They include certain medications, infections, environmental chemicals, and maternal metabolic conditions. The damage a teratogen inflicts depends on when during pregnancy the exposure happens, how much reaches the embryo, and the genetic makeup of both mother and child. That interplay of timing, dose, and genetics is what makes teratogenic risk so difficult to predict for any individual pregnancy, and why the same substance can devastate one fetus while leaving another apparently unharmed.
The Principles That Govern Teratogenic Harm
Much of what we understand about how teratogens work traces back to a framework developed by the embryologist James Wilson in the 1970s, known as the six principles of teratology. These principles still guide the field and focus on timing of exposure, dose-response relationships, and genetic susceptibility as the central variables that determine whether a given agent causes harm.1PubMed. The evolution of teratology: Historical perspectives and lessons learned The principles also recognize that teratogens act through specific cellular mechanisms, that the type of defect produced depends on which developmental process is disrupted, and that outcomes range from no visible effect to death of the embryo, with malformation somewhere in between.2PubMed Central. Teratology – past, present and future
What this means in practice is that there is no single “safe” or “dangerous” label for most substances. A drug that is harmless in low doses during the second trimester might cause severe defects at higher doses during the first trimester. Context is everything.
Why Timing Matters So Much
The embryo’s vulnerability to teratogens follows a predictable pattern tied to what organs are forming at any given point. The period of organogenesis, roughly weeks three through eight after conception, is when the major body structures take shape. Disruption during this window tends to produce structural malformations: missing limbs, heart defects, facial abnormalities, and neural tube defects like spina bifida. Before organogenesis, in the first two weeks, exposure either kills the embryo or causes no lasting damage, because the cells haven’t yet committed to specific fates.
But the story doesn’t end at week eight. Functional defects, particularly those involving the brain, have a much longer window of vulnerability that stretches well into fetal development. Fetal alcohol spectrum disorder illustrates this clearly. The hallmark facial features and small head size associated with full-blown fetal alcohol syndrome result from alcohol exposure early in embryogenesis. Yet alcohol exposure later in pregnancy, after the face and skull have already formed, can still cause serious neurodevelopmental problems without any visible physical abnormalities.3PubMed Central. A Barrier to Understanding Teratogenicity: The Critical Periods of Sensitivity for Most Structural Birth Defects Precede the Established Hemochorial Placenta The brain keeps developing throughout pregnancy and well into childhood, which means it remains a target long after the limbs and heart are fully formed.
How Teratogens Damage Cells
At the molecular level, many teratogens converge on a shared pathway involving oxidative stress. Developing embryonic cells rely on tightly regulated chemical signaling to decide when to multiply, when to specialize, and when to die off as part of normal sculpting. A number of teratogens throw this signaling off balance by flooding cells with reactive oxygen species, unstable molecules that damage DNA, proteins, and cell membranes.4PubMed. Oxidative stress as a mechanism of teratogenesis
Valproic acid, an anticonvulsant drug used to treat epilepsy and bipolar disorder, is one well-studied example. Research has shown that valproic acid ramps up reactive oxygen species in the developing embryo, triggering a wave of abnormal cell death in the regions that form the neural tube. When researchers added an enzyme that neutralizes those reactive molecules, both the oxidative damage and the cell death dropped, confirming that the oxidative stress was driving the harm rather than being a bystander.5Molecular Pharmacology. Valproic Acid Increases Formation of Reactive Oxygen Species and Induces Apoptosis in Postimplantation Embryos: A Role for Oxidative Stress in Valproic Acid-Induced Neural Tube Defects Valproic acid also works through a second, distinct mechanism: it inhibits enzymes called histone deacetylases, which control how tightly DNA is packaged. Blocking those enzymes scrambles the gene-expression patterns that embryonic cells need to develop properly, and studies of twenty different valproic acid variants showed a direct correlation between how strongly each variant blocked these enzymes and how severely it caused neural tube defects.6PubMed. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives
Maternal type 2 diabetes offers another window into the oxidative-stress mechanism. Poorly controlled blood sugar during pregnancy induces oxidative stress and excessive cell death in the developing heart, producing congenital heart defects through a pathway remarkably similar to what is seen with chemical teratogens.7PubMed Central. Type 2 diabetes mellitus induces congenital heart defects in murine embryos by increasing oxidative stress, endoplasmic reticulum stress, and apoptosis The takeaway is that very different exposures can funnel through overlapping cellular damage pathways.
Genetic Susceptibility Explains Why Outcomes Vary
One of the most confusing aspects of teratogenic risk is that two pregnancies with seemingly identical exposures can have completely different outcomes. Genetics is a major reason. Both the mother’s genes and the embryo’s own genes affect how a teratogen is absorbed, broken down, distributed, and recognized by cellular receptors.8PubMed. Genetic susceptibility to teratogens: state of the art A mother who metabolizes a drug quickly might expose her embryo to far less of the active compound than a mother who metabolizes it slowly, even if both take the same dose. Likewise, an embryo that carries certain gene variants may have a weaker ability to neutralize oxidative stress or repair DNA damage, making it more susceptible at any given exposure level.
This genetic variability is a big reason why blanket statements about drug safety in pregnancy are so hard to make. Animal studies help, but species differ in their metabolism, and what proves dangerous in a rat may not translate directly to humans. The reverse is also true, which is partly how thalidomide slipped through early safety testing.
The Placenta as Gatekeeper
The placenta is often described as a barrier between mother and fetus, but it’s more like a selective filter. It actively pumps certain harmful compounds back into the maternal bloodstream before they can reach the fetus, using transporter proteins embedded in its outer layer. Two of the most important are P-glycoprotein and breast cancer resistance protein, which together can extrude a wide range of foreign chemicals.9PubMed. Placental drug transporters and their role in fetal protection
However, these transporters have limits. They don’t recognize every harmful molecule, and many teratogens pass through the placenta freely. Alcohol, for instance, crosses almost without resistance, achieving concentrations in fetal blood comparable to the mother’s. The placenta also doesn’t become fully functional until well into the first trimester, meaning that during the earliest and most vulnerable weeks of organogenesis, this protective system may not yet be operating at full capacity. This is an underappreciated gap in fetal protection.
Pharmaceutical Teratogens
The most notorious pharmaceutical teratogen is thalidomide, a sedative prescribed for morning sickness in the late 1950s and early 1960s. More than 10,000 children worldwide were born with severe limb malformations and other defects before the drug was pulled from the market.10PubMed Central. Thalidomide-induced teratogenesis: history and mechanisms Thalidomide has since been repurposed for treating certain cancers and leprosy complications, but tragically, a new generation of affected children has been identified in Brazil, where the drug is used more widely and pregnancy prevention measures haven’t always been enforced.
Isotretinoin, a vitamin A derivative prescribed for severe acne, is another well-known teratogen. Prenatal exposure produces a characteristic pattern of defects affecting the skull, ears, heart, and brain.11PubMed Central. Retinoic Acid Embryopathy Because the risks are so clearly established, prescribing programs for isotretinoin in many countries require documented pregnancy tests and contraception commitments before dispensing the drug.
What makes pharmaceutical teratogens particularly tricky is that the mother often needs the medication. A woman with epilepsy can’t simply stop her anticonvulsant during pregnancy, because uncontrolled seizures also pose serious risks to the fetus. The clinical challenge is finding the least harmful drug at the lowest effective dose, a balancing act that underscores why pregnancy care often requires specialist input.
Infections That Act as Teratogens
Certain viruses and parasites can cross the placenta and directly damage developing fetal tissues. The classic group is known by the acronym TORCH, which includes toxoplasmosis, rubella, cytomegalovirus (CMV), and herpes simplex, though the list has expanded over the years.
Cytomegalovirus is the most common congenital infection in many countries. It damages the fetal brain primarily by disrupting the migration of neurons to their correct positions, which leads to structural brain abnormalities.12PubMed. Congenital CMV infection and central nervous system involvement: mechanisms, treatment, and long-term outcomes CMV is also a leading infectious cause of childhood hearing loss, through both direct damage to inner-ear structures and the inflammation that the immune response triggers.13PubMed Central. CMV-induced Hearing Loss
Zika virus drew global attention starting in 2015 for causing microcephaly, a condition in which the brain and skull are abnormally small. Research has shown that Zika preferentially infects neural progenitor cells, the stem cells that generate the brain’s neurons. Undifferentiated progenitor cells are the most permissive to the virus, meaning that infection strikes hardest at exactly the cells the developing brain depends on most.14PubMed Central. Zika virus differentially infects human neural progenitor cells according to their state of differentiation and dysregulates neurogenesis through the Notch pathway In mouse models, Zika infection caused these progenitor cells to stop dividing and begin dying, directly thinning the cortex and producing microcephaly.15PubMed. Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice Further work identified that Zika triggers a specific type of inflammatory cell death in neural progenitors, offering a potential target for treatment.16PubMed Central. Neural progenitor cell pyroptosis contributes to Zika virus-induced brain atrophy and represents a therapeutic target
Environmental and Lifestyle Exposures
Methylmercury, an organic form of mercury that accumulates in fish, is one of the most thoroughly documented environmental teratogens. The catastrophe in Minamata, Japan, in the 1950s provided devastating proof: children born to mothers who ate mercury-contaminated seafood appeared normal at birth but went on to develop symptoms resembling cerebral palsy, including difficulty with head control, sitting, walking, and mental development.17PubMed. Effects of Prenatal Methylmercury Exposure: From Minamata Disease to Environmental Health Studies The delay between birth and the appearance of symptoms highlights how some teratogenic damage only becomes visible as the child’s brain matures and faces increasingly complex demands.
Alcohol remains the most common preventable cause of birth defects and intellectual disability in many countries. Brain imaging studies of people with fetal alcohol spectrum disorders show widespread reductions in brain volume, abnormalities in the shape of specific brain regions, and changes in white and grey matter density.18PubMed Central. Foetal Alcohol Spectrum Disorders and alterations in brain and behaviour Importantly, researchers have demonstrated that different teratogens can produce distinct patterns of cognitive impairment even when exposure occurs during the same developmental window. Comparing the effects of prenatal alcohol, polychlorinated biphenyls (PCBs), and cocaine on infant cognitive tests reveals that each substance leaves a different fingerprint on brain function, rather than all producing generic “brain damage.”19PubMed. Specificity of neurobehavioral outcomes associated with prenatal alcohol exposure
Tobacco smoking during pregnancy affects fetal growth in ways that go well beyond lower birth weight. Fetal MRI studies have shown that smoking mothers’ fetuses had lower brain volume, lower kidney volume, lower lung volume, and smaller overall fetal size compared to unexposed fetuses. The kidney differences actually widened as pregnancy progressed, suggesting a cumulative effect rather than a one-time insult.20PubMed Central. Maternal Smoking during Pregnancy and Fetal Organ Growth: A Magnetic Resonance Imaging Study
Endocrine Disruptors and Low-Dose Effects
A newer and more contentious area of teratology involves endocrine-disrupting chemicals, substances that mimic or interfere with hormones at very low concentrations. Bisphenol A (BPA), found in certain plastics and food-can linings, is one of the most studied. Research has found that low doses of BPA altered the development of the male urogenital tract in rats, including changes to the size of internal structures, and that these effects did not follow a straightforward “more dose, more damage” pattern. Instead, only lower doses produced significant changes, while higher doses sometimes did not, a phenomenon called a nonmonotonic dose-response.21PubMed Central. Fetal bisphenol A and ethinylestradiol exposure alters male rat urogenital tract morphology at birth: Confirmation of prior low-dose findings in CLARITY-BPA
This nonmonotonic behavior makes endocrine disruptors unusually difficult to regulate. Traditional toxicology assumes that reducing the dose reduces the harm, which lets regulators set a threshold below which a substance is considered safe. When the dose-response curve isn’t a straight line, that assumption breaks down, and setting safe limits becomes far more complicated. The debate over how to handle these chemicals in consumer products remains unresolved in regulatory agencies worldwide.
The Role of Folate in Prevention
Not all interactions between nutrients and development involve harm. Folic acid supplementation before and during early pregnancy is one of the most successful preventive measures in all of teratology. Folate is essential for DNA synthesis and for the methylation reactions that regulate gene expression in rapidly dividing embryonic cells. When these processes are impaired, the neural tube may fail to close properly, leading to defects like spina bifida and anencephaly.22PubMed. Folic acid metabolism and mechanisms of neural tube defects
What is interesting about the folic acid story is that most women who have neural tube defect-affected pregnancies are not actually folate-deficient by standard measures. The supplementation appears to work by overwhelming a metabolic bottleneck, pushing enough folate through the relevant biochemical pathways to compensate for a subtle processing problem rather than correcting outright deficiency. This is why the effective dose for prevention is higher than what you’d need to treat a simple dietary shortfall. It also explains why fortifying staple foods like flour with folic acid, which many countries began doing in the late 1990s, has been so effective at the population level.
Paternal Exposures and Sperm-Mediated Effects
Teratology has traditionally focused almost entirely on maternal exposures, for the obvious reason that the mother’s body is the environment in which the embryo develops. But emerging research suggests that a father’s chemical exposures before conception can also affect offspring development, through changes to sperm that go beyond DNA mutations. In a 2023 study, male mice treated with methotrexate, a drug used for cancer and autoimmune conditions, produced sperm with altered small non-coding RNA content and RNA methylation patterns. When the RNA fraction from those treated sperm was injected into normal fertilized eggs, the resulting offspring developed craniofacial defects.23PubMed Central. Paternal methotrexate exposure affects sperm small RNA content and causes craniofacial defects in the offspring
This is still a young area of research, and translating mouse findings directly to humans requires caution. But the implication is that pre-conception counseling about drug and chemical exposures shouldn’t be directed exclusively at women. If sperm can carry a chemical’s developmental effects forward through RNA modifications, the traditional view that the father’s only contribution is DNA will need updating.
How Drug Safety in Pregnancy Is Labeled
For decades, the U.S. FDA assigned prescription drugs letter categories (A, B, C, D, X) to indicate their risk during pregnancy, a system that was widely used but deeply flawed. The letters implied a clean ranking from safe to dangerous, when in reality the categories often reflected how much data existed rather than how dangerous a drug actually was. A drug in category C might be there simply because no human studies had been done, not because it was known to be risky.
In 2015, the FDA replaced this system with the Pregnancy and Lactation Labeling Rule, which requires drug labels to include narrative descriptions of risk information, clinical considerations, and available data instead of a single letter grade.24PubMed. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule The new labels are more informative but also harder to interpret quickly, which puts a greater burden on clinicians to read and contextualize the information. If you’re pregnant and looking up a medication, the old A-through-X categories may still appear in older references, but they’re no longer the standard and shouldn’t be relied on as a definitive safety guide.
Screening for Teratogens Without Animal Testing
Identifying whether a new chemical or drug is teratogenic before it reaches the market has historically required extensive animal testing, which is expensive, slow, and imperfect at predicting human outcomes. A promising alternative uses human stem cells grown in laboratory dishes to model early development. Researchers expose these cells to test compounds and measure whether key developmental processes, like the formation of specific cell types, are disrupted.25PubMed Central. Teratogen screening with human pluripotent stem cells
One such platform, the human pluripotent stem cell test, gauges teratogenic risk by measuring how much a compound disrupts the formation of a particular cell lineage over a three-day period. When benchmarked against 71 drug-like compounds with known in vivo effects, the assay achieved about 94% accuracy in distinguishing teratogens from non-teratogens and performed similarly well with a panel of environmental toxicants.26Toxicological Sciences. A High-Throughput Screen for Teratogens Using Human Pluripotent Stem Cells These platforms don’t capture the complexity of a whole pregnancy, including placental transport, maternal metabolism, and organ-level interactions. But as a first-pass screen they could substantially reduce both the number of animals used in testing and the chances that a harmful compound advances to later development stages undetected.